releases: https://www.booker.senate.gov/news/press/booker-schumer-wyden-urge-doj-to-reschedule-marijuana
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.booker.senate.gov/news/press/booker-schumer-wyden-urge-doj-to-reschedule-marijuana | Booker, Schumer, Wyden Urge DOJ to Reschedule Marijuana | 2024-08-02 | 2024 | 2024-08 | Democrat | Senate | NJ | Cory A. Booker | B001288 | www.booker.senate.gov | booker | https://www.booker.senate.gov/news/press | scraper | WASHINGTON, D.C. – Today, U.S. Senator Cory Booker (D-NJ), Majority Leader Chuck Schumer (D-NY), and Finance Committee Chair Ron Wyden (D-OR), along with Senators Tina Smith (D-MN), Ben Ray Luján (D-NM), Patty Murray (D-WA), and Kirsten Gillibrand (D-NY) sent a letter to Attorney General Merrick Garland and DEA Administrator Anne Milgram, expressing their strong support for the Drug Enforcement Administration’s (DEA) proposal to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). “We write to express support for the Drug Enforcement Administration’s proposal to transfer marijuana from schedule I to schedule III of the Controlled Substances Act (“CSA”). The proposed rule to reclassify marijuana to schedule III recognizes the medical benefits of marijuana, will improve access for studying the health effects of short and long-term cannabis use, and will provide relief to cannabis businesses that continue to navigate a patchwork regulatory system to conduct legal business,” the Senators wrote. “On October 6, 2022, President Biden directed the Secretary of Health and Human Services and the Attorney General to initiate the administrative review process to review expeditiously how marijuana is scheduled under federal law. In 2023, after undertaking the eight-factor analysis required under the CSA, HHS found, and recommended to DEA, that marijuana did not meet the criteria to continue classification as a Schedule I substance and that it be transferred to Schedule III,” the Senators continued. HHS conducted a two-part inquiry to consider the Current Accepted Medical Use (CAMU) of marijuana, and concluded that it has a CAMU to treat pain, anorexia, nausea, vomiting, among other ailments, without posing ‘unacceptably high safety risks.’ “Rescheduling presents significant benefits to public health, research, business, and Americans harmed by the lasting effects of our punitive drug policies. It will also bolster cannabis-related businesses, many of which are owned by people criminalized for marijuana offenses, opening them up to critical investment opportunities.” The Senators also emphasized the need to pass comprehensive legislation, like the Cannabis Administration and Opportunity Act (CAOA), to fully end federal prohibition and establish a federal regulatory framework that prioritizes restorative justice and public health. Senators Booker, Schumer, and Wyden led the reintroduction of the CAOA earlier this year. “Rescheduling is not the panacea to undoing the harms caused by decades of marijuana prohibition, but it is a step toward addressing the policies that have devastated communities across the country. Cannabis should be entirely de-scheduled. Yet, we recognize and appreciate DEA’s effort to address the flaws in our current marijuana policy by using its authority under the CSA and following the scientific and medical evidence to reschedule marijuana as a Schedule III drug. We urge DEA to finalize the rule,” the Senators concluded. | 1 | 2026-03-30T01:40:41Z | 2026-04-07T21:36:13Z |